View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
GMALL 08/2013 - ALL/LBL Induction II (Day 23), 18 - 55 years, all risk groups
Protocol-ID: 594 V2.0 (Mini), GMALL 08/2013-ALL/LBL Induction II (d23), 18 - 55, all risk groupsIndication(s)
- Acute Lymphoblastic Leukaemia (Ph/BCR-ABL-); ICD-10 C91.0-
- NHL, B-Cell Type, Lymphoblastic Lymphoma; ICD-10 C83.5
- NHL, T-Cell Type, Lymphoblastic Lymphoma; ICD-10 C83.5
ST Radiotherapy: CNS irradiation |
| 24 Gy in parallel with induction phase II chemotherapy |
Links
- Studie GMALL08_2013, Treatment Optimization in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment - a Phase IV-trial With a Phase III-part to Evaluate Safety and Efficacy of Nelarabine in T-ALL Patients [clinicaltrials.gov]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 19.04.2018